Results 201 to 210 of about 20,692 (311)

Pemphigoid gestationis treated with dupilumab

open access: yesJAAD Case Reports, 2023
Chen, Rita E   +2 more
openaire   +4 more sources

Prescribing for the Planet: Integrating Life Cycle Analyses Into Therapeutic Decision‐Making in Dermatology

open access: yes
International Journal of Dermatology, EarlyView.
Eva Rawlings Parker   +2 more
wiley   +1 more source

Th2 mRNA gene expression analysis separates Prurigo nodularis into two immune signature groups

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Protein expression, histology and RNA analyses were performed from patients with prurigo nodularis (PN). All patients had typical PN characteristics. Lymphocytes/monocytes demonstrated more frequent positive staining signals in lesional versus non‐lesional samples for IL‐31, IL‐31RA, OSM and OSMRb.
Sonja Ständer   +20 more
wiley   +1 more source

Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP

open access: bronze, 2019
Claus Bachert   +15 more
openalex   +1 more source

Effectiveness and Safety of Omalizumab for Chronic Spontaneous Urticaria During Pregnancy: A Systematic Review

open access: yes
International Journal of Dermatology, EarlyView.
Ioannis‐Alexios Koumprentziotis   +3 more
wiley   +1 more source

The Dental Status of Patients Taking Common Biologic Agents: A Single‐Center Cross‐Sectional Study

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives Despite expanding use and medical applications, little is known about the impact of biologic agents (BAs) on dental treatment. The aim of this study was to investigate the dental status of patients on common classes of BAs to understand treatment needs and use in this population.
Shivani Shah   +4 more
wiley   +1 more source

Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 Data [PDF]

open access: hybrid, 2020
Pavel Kovalenko   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy